News | September 05, 2025
MedTech Expo 2025: ICMR licenses nine technologies to 17 industry partners
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
Enlicitide achieved all primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
The positive benefit-risk profile of vericiguat in its approved indication in patients with HFrEF following a recent heart failure event based on the pivotal Phase III VICTORIA trial remains unchanged
Zilebesiran, a potential best-in-disease RNAi anti-hypertensive with twice-yearly subcutaneous dosing, demonstrated encouraging safety when combined with two or more antihypertensives
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
Subscribe To Our Newsletter & Stay Updated
